Exosome hair loss study halted early – what we know
NCT ID NCT06932393
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether exosomes from donated stem cells could help people with hair loss. It was a small, early-phase trial with 16 participants, comparing treated areas to untreated ones. The study was terminated early, so results are limited. The goal was to see if the treatment was safe and could increase hair density.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALOPECIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shenzhen Qianhai Shekou Free Trade Zone Hospital
Shenzhen, Guangdong, 518067, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A tiny drop of blood might be enough: study tests fingerstick accuracy
- Blood test may reveal hidden clues to hair loss severity
- Hair loss linked to gut and scalp bacteria in new study
- Braids and conditioner may boost scalp cooling against chemo hair loss
- Cooling caps may keep hair on during pancreatic cancer chemo
- New scalp formula shows promise for hair regrowth in small study